Prevalence and predictors of cirrhosis and portal hypertension in the United States

The prevalence of cirrhosis in the United States is 2.6% while the prevalence of CS-portal hypertension is 0.98%. Individuals with MASLD comprise the majority of US residents with cirrhosis.

Authors

Institutions

Publication Details

Journal
Hepatology
Published
2025-01-29
DOI
https://doi.org/10.1097/hep.0000000000001243
Citations
15
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
19.83
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence and predictors of cirrhosis and portal hypertension in the United States

Andrei Racila, Leyla de Avila, James M. Paik, Linda Henry et al.
15 citations
Hepatology
Liver Disease and Transplantation
19.83
article

Prevalence and predictors of cirrhosis and portal hypertension in the United States

Andrei Racila, Leyla de Avila, James M. Paik, Linda Henry, Maria Stepanova, Fatema Nader, Z.M. Younossi
article en
15 citations

Abstract

The prevalence of cirrhosis in the United States is 2.6% while the prevalence of CS-portal hypertension is 0.98%. Individuals with MASLD comprise the majority of US residents with cirrhosis.

HepatologyVol. 82(5)
Inova Health System (US), Center for Outcomes Research in Liver Diseases (US)
Openalex Percentile: Top 0%
Liver Disease and Transplantation
19.83
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.